Table 3 Demographics of patients not receiving coronary angiogram for alternate year included in the study, from 2004–2014.
Number of Cases | 2004 | 2006 | 2008 | 2010 | 2012 | 2014 |
|---|---|---|---|---|---|---|
207,084 | 184,979 | 182,214 | 158,144 | 148,900 | 142,455 | |
Age (year), Median IRQ | 75(61–84) | 76(62–84) | 77 (64–86) | 77 (64–86) | 77 (64–86) | 76 (64–86) |
Men % | 49.0% | 49.4% | 49.3% | 49.3% | 50.0% | 51.2% |
Ethnicity | ||||||
White | 56.6% | 57.2% | 62.7% | 65.5% | 71.1% | 70.9% |
Black | 9.4% | 8.7% | 8.5% | 12.4% | 11.3% | 12.1% |
Hispanic | 5.8% | 6.9% | 5.5% | 6.2% | 7.4% | 7.5% |
Asian/Pacific Islander | 1.5% | 1.7% | 1.8% | 2.3% | 2.3% | 2.1% |
Native American | 0.3% | 0.4% | 0.5% | 0.6% | 0.5% | 0.5% |
Other | 1.9% | 1.5% | 2.3% | 2.1% | 2.6% | 2.6% |
Missing Race | 24.5% | 23.6% | 18.6% | 10.8% | 4.7% | 4.3% |
Weekend admission | 26.6% | 26.0% | 27.2% | 27.3% | 26.5% | 26.9% |
Primary expected payer, % | ||||||
Medicare | 68.6% | 70.5% | 72.0% | 72.9% | 75.1% | 74.4% |
Medicaid | 6.0% | 5.2% | 5.5% | 5.8% | 6.1% | 7.5% |
Private Insurance | 19.4% | 18.2% | 17.1% | 15.1% | 13.0% | 13.3% |
Self-pay | 4.0% | 4.0% | 3.1% | 3.7% | 3.6% | 2.8% |
No charge | 0.3% | 0.3% | 0.2% | 0.4% | 0.3% | 0.3% |
other | 1.8% | 1.8% | 2.1% | 2.0% | 1.9% | 1.7% |
Median Household Income (percentile) | ||||||
0–25th | 31.1% | 30.1% | 28.9% | 30.5% | 31.7% | 30.3% |
26–50th | 27.8% | 26.7% | 28.5% | 26.9% | 25.6% | 27.0% |
51–75th | 21.2% | 22.3% | 21.8% | 23.2% | 22.6% | 22.7% |
76–100th | 20.0% | 20.9% | 20.8% | 19.4% | 20.1% | 20.0% |
Comorbidities, % | ||||||
Dyslipidaemia | 28.6% | 32.3% | 35.5% | 40.4% | 44.9% | 46.8% |
Smoking | 15.3% | 17.9% | 19.3% | 24.1% | 27.9% | 33.9% |
Previous AMI | 7.3% | 7.8% | 8.4% | 10.6% | 11.7% | 11.9% |
History of IHD | 36.2% | 38.7% | 42.1% | 44.7% | 47.7% | 47.9% |
Previous PCI | 4.6% | 5.1% | 6.3% | 8.6% | 11.0% | 12.4% |
Previous CABG | 8.4% | 8.6% | 8.9% | 10.7% | 11.9% | 12.5% |
Previous CVA | No data | No data | 3.8% | 6.5% | 7.6% | 8.6% |
Family history of CAD | 2.6% | 2.8% | 2.9% | 3.7% | 3.9% | 4.5% |
Valvular heart disease | 0.3% | 0.4% | 0.4% | 0.5% | 0.5% | 0.3% |
Peripheral vascular disease | 8.4% | 9.4% | 11.3% | 12.5% | 13.8% | 14.6% |
Use of assist devise or IABP | 0.3% | 0.5% | 0.5% | 0.4% | 0.7% | 0.9% |
Shock | 1.6% | 1.7% | 1.7% | 2.2% | 2.9% | 3.4% |
AIDS | 0.14% | 0.08% | 0.12% | 0.15% | 0.11% | 0.15% |
Alcohol abuse | 2.0% | 2.2% | 2.4% | 2.4% | 2.7% | 2.9% |
Deficiency anaemias | 13.9% | 15.7% | 20.9% | 22.7% | 25.3% | 25.1% |
Chronic Blood loss anaemia | 1.9% | 2.0% | 1.6% | 1.4% | 1.3% | 1.1% |
RA/collagen vascular diseases | 1.8% | 2.0% | 2.3% | 2.7% | 2.8% | 2.9% |
Congestive heart failure | 1.3% | 1.0% | 1.3% | 1.6% | 1.2% | 1.2% |
Chronic pulmonary disease | 23.5% | 24.9% | 24.9% | 24.9% | 26.7% | 27.0% |
Coagulopathy | 2.8% | 3.2% | 3.7% | 4.6% | 6.1% | 6.7% |
Depression | 5.4% | 6.3% | 7.8% | 8.6% | 9.6% | 10.1% |
Diabetes | 27.2% | 28.4% | 29.7% | 31.1% | 32.7% | 33.2% |
Diabetes with complications | 5.9% | 6.4% | 7.3% | 7.6% | 8.5% | 9.7% |
Drug abuse | 1.3% | 1.6% | 1.5% | 1.8% | 2.0% | 2.6% |
Hypertension | 59.1% | 63.5% | 67.6% | 71.4% | 74.5% | 76.4% |
Hypothyroidism | 9.0% | 10.3% | 12.7% | 13.7% | 15.7% | 16.0% |
Liver disease | 1.1% | 1.2% | 1.2% | 1.5% | 1.8% | 2.2% |
Lymphomas | 0.5% | 0.5% | 0.7% | 0.7% | 0.8% | 0.8% |
Fluid and electrolyte disturbances | 19.3% | 21.5% | 25.1% | 26.1% | 29.1% | 30.8% |
Other neurological disorders | 7.0% | 7.9% | 9.6% | 10.0% | 10.4% | 10.2% |
Obesity | 6.1% | 6.8% | 8.5% | 9.2% | 11.7% | 13.6% |
Paralysis | 2.2% | 2.3% | 3.1% | 2.8% | 2.7% | 2.7% |
Psychoses | 1.9% | 2.1% | 2.7% | 3.1% | 3.3% | 3.5% |
Pulmonary circulation disorder | 0.06% | 0.06% | 0.2% | 0.2% | 0.2% | 0.2% |
Renal failure (chronic) | 10.8% | 21.1% | 24.5% | 29.1% | 32.4% | 34.0% |
Peptic ulcer disease | 0.07% | 0.05% | 0.04% | 0.06% | 0.02% | 0.03% |
Weight loss | 1.8% | 1.9% | 3.1% | 3.8% | 4.6% | 4.6% |
Solid tumour without Mets | 1.7% | 1.8% | 2.2% | 2.3% | 2.2% | 2.2% |
Metastatic cancer | 1.2% | 1.3% | 1.6% | 1.5% | 1.6% | 1.8% |
Dementia | 8.9% | 10.8% | 13.2% | 14.9% | 15.9% | 15.4% |
Comorbidities - Charlson Comorbidity Index | ||||||
0 | 28.4% | 26.8% | 23.6% | 21.0% | 19.0% | 17.6% |
1 | 32.8% | 33.6% | 32.4% | 30.8% | 29.5% | 28.7% |
2 | 23.2% | 23.9% | 24.8% | 25.3% | 25.5% | 25.6% |
≥3 | 15.6% | 15.7% | 19.2% | 22.9% | 26.0% | 28.1% |
Hospital bed size | ||||||
Small | 15.9% | 16.7% | 16.0% | 13.7% | 16.4% | 22.3% |
Medium | 28.6% | 27.9% | 26.5% | 27.2% | 29.1% | 31.3% |
Large | 55.5% | 55.4% | 57.5% | 59.1% | 54.5% | 46.4% |
Hospital Region | ||||||
Northeast | 26.9% | 28.6% | 24.5% | 24.9% | 25.5% | 24.7% |
Midwest | 21.5% | 19.0% | 21.1% | 21.8% | 20.2% | 20.4% |
South | 38.1% | 38.3% | 39.5% | 38.5% | 37.6% | 37.9% |
West | 13.5% | 14.1% | 14.9% | 14.8% | 16.7% | 17.0% |
Location/Teaching status | ||||||
Rural | 21.6% | 19.6% | 17.9% | 17.9% | 16.0% | 13.7% |
Urban-non teaching | 50.5% | 45.6% | 50.1% | 48.1% | 45.0% | 32.8% |
Urban- teaching | 27.9% | 34.8% | 32.0% | 34.0% | 39.0% | 53.5% |
Length of stay, Median (IQR) | 3(2–6) | 3 (2–6) | 3 (2–6) | 3 (2–6) | 3 (2–6) | 3 (2–6) |
Total charge,$, Median (IQR) | 13153 (7219–25739) | 15770 (8585–30362) | 18276 (10103–33945) | 18830 (10586–34652) | 21862 (12141–40742) | 24223 (13606–45146) |
Bleeding complications | 11.2% | 11.7% | 12.7% | 12.2% | 11.9% | 10.6% |
Vascular complications | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.5% |
Cardiac complication | 0.3% | 0.5% | 0.4% | 0.4% | 0.5% | 0.6% |
In-hospital mortality | 6.8% | 6.6% | 6.7% | 6.4% | 7.0% | 6.7% |
